HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relative iron deficiency in hereditary spherocytosis.

Abstract
Seventy-three patients with hereditary spherocytosis (HS) (58 nonsplenectomized, 15 splenectomized) were studied to evaluate iron status and the adequacy of iron availability for erythropoiesis. Splenectomized patients, who had hemoglobin levels in the normal or upper normal range, had higher levels of serum iron, transferrin saturation, and serum ferritin than normal matched controls and normal zinc protoporphyrin (ZnPP) levels. On the contrary, nonsplenectomized patients presenting with mild to severe anemia had higher red cell ZnPP concentrations than both splenectomized subjects and matched normal controls. ZnPP in nonsplenectomized patients correlated inversely with Hb concentration, mean corpuscular volume (MCV), mean red cell hemoglobin concentration (MCHC), transferrin saturation, and serum iron, and directly with reticulocyte count. At multiple regression analysis only Hb concentration was a significant explanatory variable for high ZnPP. The authors conclude that a number of nonsplenectomized HS patients have relative iron deficiency primarily because of expansion of erythropoiesis caused by anemia.
AuthorsA Zanella, G Barosi, A Berzuini, M B Colombo, S Quaglini, D Volpes, G Sirchia
JournalAmerican journal of hematology (Am J Hematol) Vol. 31 Issue 2 Pg. 81-6 (Jun 1989) ISSN: 0361-8609 [Print] United States
PMID2735320 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Protoporphyrins
  • zinc protoporphyrin
  • Iron
Topics
  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Erythrocyte Indices
  • Female
  • Humans
  • Iron (blood)
  • Iron Deficiencies
  • Male
  • Middle Aged
  • Protoporphyrins (blood)
  • Regression Analysis
  • Spherocytosis, Hereditary (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: